C07F 9 - Compounds containing elements of the 5th group of the periodic system

Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
10/2002
10/30/2002	EP1252169A1 Process for making geminal bisphosphonates
10/30/2002	EP1252168A1 Salt of a melamine condensation product and a phosphorus-containing acid
10/30/2002	EP1252166A1 Olefin polymerization cocatalysts derived from group-15 cationic compounds and processes using them
10/30/2002	EP1252133A2 Pharmaceutical compounds
10/30/2002	EP1105359B1 Solid phase synthesis of compounds by carbon-carbon bond forming mitsunobu reactions
10/30/2002	EP1090016B1 The preparation of arylphosphines
10/30/2002	EP0775126B1 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides
10/30/2002	CN1377261A Treatment of immune diseases
10/29/2002	US6472558 Iridium compound such as iridium hexachloride and methyl iodide catalyzed carbonylation of carbon monoxide and methanol in presence of polydentate alkyl or aryl phosphine oxide; increased selectivity; by product inhibition
10/29/2002	US6472550 Process for the preparation of low chloride stabilizers
10/29/2002	US6472547 Process for producing bismuth tertiary amyloxide
10/29/2002	US6472541 Halogenated- coumarin, quinoline-2-one, xanthene, thioxanthene, selenoxanthenen, or anthracene derivatives; irradiating to control the release of the sompound spatially and temporally to probe its biological effects
10/29/2002	US6472539 Production process of diphosphine oxide and diphosphonate
10/29/2002	US6472533 Ligands for chiral catalysis
10/29/2002	US6472419 1-H-3-aryl-pyrrolidine-2, 4-dione derivatives as pest-control agents
10/29/2002	US6472414 Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
10/29/2002	US6472411 Advanced glycation end-product intermediaries and post-amadori inhibition
10/29/2002	US6472406 Sulfonamidomethyl phosphonate inhibitors of beta-lactamase
10/29/2002	CA2179988C Pharmaceutical formulations comprising polythiourea and method of use thereof
10/25/2002	EP1175423A4 Weakly coordinating anions containing polyfluoroalkoxide ligands
10/24/2002	WO2002083988A2 Micro-engineered reactors
10/24/2002	WO2002083720A2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
10/24/2002	WO2002083697A1 Heterocyclically substituted (thio)phosphoric triamides
10/24/2002	WO2002083696A2 Novel cyclo azaphospha hydrocarbons
10/24/2002	WO2002083695A1 Ligands for pnicogen chelate complexes with a metal of subgroup viii and use of the complexes as catalysts for hydroformylation, carbonylation, hydrocyanation or hydrogenation
10/24/2002	WO2002083150A1 Bisphosphonate conjugates and methods of making and using the same
10/24/2002	WO2002083092A1 Water-in-stable kojic acid derivatives and method for preparing thereof, and whitening cosmetics composition containing the same
10/24/2002	WO2002083071A2 Heterocyclic analgesic compounds and methods of use thereof
10/24/2002	WO2002067999A3 Actinium-225 complexes and conjugates for targeted radiotherapy
10/24/2002	WO2002022626A8 Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds
10/24/2002	US20020156295 Coordination catalyst containing ligand
10/24/2002	US20020156279 Substituted pyridyl amine catalysts and processes for polymerizing crystalline polymers
10/24/2002	US20020156217 Poly (phosphonoarylacetylene and chiral sensor comprising the same
10/24/2002	US20020156212 Catalyst systems of alpha -diimine, urethane or urea ligands complexed to nickel, palladium or other transition metals
10/24/2002	US20020156081 Pyrazolopyrimidines as therapeutic agents
10/24/2002	US20020156053 Treating gastro-oesophageal reflux disease
10/24/2002	US20020156049 Highly packed polycationic ammonium, sulfonium and phosphonium lipids
10/24/2002	US20020155484 Oligonucleotide for use as tool in the detection of preferential compounds in solution
10/24/2002	US20020153504 Storage stabilitiy
10/24/2002	CA2770489A1 Bisphosphonate conjugates and methods of making and using the same
10/24/2002	CA2443874A1 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
10/24/2002	CA2443709A1 Novel cyclo azaphospha hydrocarbons
10/23/2002	EP1250474A2 Tellurium-containing nanocrystalline materials
10/23/2002	EP1250341A1 A method of generating a functionalised arylphosphine
10/23/2002	EP1250315A1 Functional monomers for molecular recognition and catalysis
10/23/2002	EP1073664B1 (alpha-aminophosphino) peptidesderivative and compositions containing same
10/23/2002	EP1066297B1 Phosphinic acid derivatives
10/23/2002	EP1017480B1 Method for separating actinides and lanthanides by membrane transport using a calixarene
10/23/2002	EP0925303B1 Phosphinic acid amides as matrix metalloprotease inhibitors
10/23/2002	EP0767170B1 Novel 4,6-diarylpyrimidine derivatives and salts thereof
10/23/2002	CN1376144A Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
10/23/2002	CN1093132C Metallocene compounds
10/23/2002	CN1093131C Process for preparing ascorbic acid-2-phosphates
10/22/2002	US6469225 By an alkane cross-metathesis reaction using a supported organometallic compound to produce branched alkanes
10/22/2002	US6469189 Liquid double alkoxide of niobium or tantalum and alkaline earth metal, production method thereof, and production method of complex metal oxide dielectric using it
10/22/2002	US6469162 Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy and diagnosis
10/22/2002	US6469120 Water-stabilized organosilane compounds and methods for using the same
10/22/2002	US6468992 Phosphonic acid diester derivatives
10/22/2002	CA2227264C Amine acid salt compounds and process for the production thereof
10/22/2002	CA2073634C Process for the production of vanadium bis-arenes from vanadium oxychloride
10/17/2002	WO2002081487A1 Low concentration rates
10/17/2002	WO2002081486A1 Fluorous phosphines and phosphine oxides
10/17/2002	WO2002081466A1 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
10/17/2002	WO2002080926A1 Pyrazolopyrimidines as therapeutic agents
10/17/2002	US20020151742 Process for producing vitamin a ester
10/17/2002	US20020151739 From reacting tert-butylhydroquinone and monophenyl dichlorophosphate in presence of acid catalyst; flame retardants
10/17/2002	US20020151735 Such as (S)-ps-ortho-Bis(bis(dimethylamino)phosphino)-(2.2)-p-cyclophane; useful as chemical intermediates for transition metal-catalysed asymmetric hydrogenation reactions
10/17/2002	US20020151731 Such as bis-1,2-(2-(2,3-epoxypropyl)phenoxy)ethane; chemical intermediates for formation of epoxy resins
10/17/2002	US20020151725 Detecting phosphatidylcholine-specific phospholipase-C enzyme via incorporation of 3-indoxyl choline phosphate into substrate
10/17/2002	US20020151503 Methods of cancer treatment using naaladase inhibitors
10/17/2002	US20020151444 Bisdithiophosphoric acid derivatives as lubricant additives
10/17/2002	US20020150950 Solid phase quenching systems
10/17/2002	US20020148786 Removal and recovery of chloride from phosphonomethyliminodiacetic acid process brine
10/17/2002	DE10201458A1 New proteins involved in isoprenoid biosynthesis, useful in screening for inhibitors, also new intermediates, potential therapeutic agents, nucleic acids and antibodies
10/17/2002	DE10164041A1 Verfahren zur Herstellung von Vitamin-A-ester A process for producing vitamin A ester
10/17/2002	DE10118322A1 New N-heterocyclyl-phosphoric acid triamide derivatives, useful as urease inhibitors, particularly as additives for urea-based fertilizers, feeds, and manure
10/17/2002	CA2440724A1 Pyrazolopyrimidines as therapeutic agents
10/16/2002	EP1249455A1 Phosphonium salts and processes for production of and uses for the same, and phosphines deriving the same and processes for production of the phosphines
10/16/2002	EP1248790A1 Proton pump inhibitors
10/16/2002	EP1206574A4 Guanidinium functionalized oligomers and methods
10/16/2002	EP1019417B1 Phospholipid analogue compounds
10/16/2002	EP0968216B1 Phosphine ligands with amino acid groups, method for their production and use thereof as catalyst components
10/16/2002	EP0944385B1 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating helicobacter pylori infections and the gastroduodenal diseases associated therewith
10/16/2002	CN1374965A Hydroformylation using multidentate phosphite ligands
10/16/2002	CN1374953A Aromatic nitrogenous six-membered ring compounds
10/16/2002	CN1374943A Multidentate phosphite ligands, catalytic compositions containing such ligands and catalytic processes utilizing such catalytic compositions
10/16/2002	CN1374942A Multidentate phosphite ligands, catalytic compositions containing such ligands and catalytic processes utilizing such catalytic compositions
10/16/2002	CN1374935A Hydroformylation process utilizing multidentate phosphite ligands
10/16/2002	CN1374886A Hydroformylation of unsaturated compounds using polymeric phosphite ligands
10/16/2002	CN1374833A Pesticide formulations containing phosphate ester surfactant and alkoxylated lignosulfonate
10/16/2002	CN1374314A Amorphous Adefuweizhi ester amorphous solid matter and its prepn
10/16/2002	CN1374313A Modified phospholipid of poly alkyl oxygen and its producing process
10/16/2002	CN1092666C Alkali penetrating agent
10/15/2002	US6465687 Thyroid receptor ligands and method
10/15/2002	US6465684 Process for the separation of a mixture of enantiomers
10/15/2002	US6465649 Forming trimethylsilyl phosphonate by reaction of the phosphonate with chlorotrimethylsilane and hydrolyzing to provide for a phosphonic acid or a salt
10/15/2002	US6465643 Aminophosphonium compounds
10/15/2002	US6465594 Phosphine derivative and polymer thereof and transition metal complex comprising the same
10/15/2002	US6465495 Preparation of pyridone-based phosphotyrosine mimetics and uses thereof
10/15/2002	US6465450 Vanadium (IV) complexes containing catecholate ligand and having spermicidal activity

1 ... 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 ... 554